4.6 Article

Interferon-Gamma Primed Human Clonal Mesenchymal Stromal Cell Sheets Exhibit Enhanced Immunosuppressive Function

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity

Karolina Piekarska et al.

Summary: Transfer of mitochondria from mesenchymal stem cells to allogeneic Treg cells enhances the immunosuppressive functions of Treg cells, providing potential for the development of cell-based immunotherapies.

NATURE COMMUNICATIONS (2022)

Article Immunology

Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells

Huldani Huldani et al.

Summary: Inflammatory bowel disease (IBD) is caused by various pathophysiologic pathways and immune-pathologic etiologies. Mesenchymal Stem Cells (MSCs) have been suggested as a potential treatment for IBD due to their immune regulatory functions. Clinical trials using MSCs from bone marrow, umbilical cord, and adipose tissue have shown promising results in terms of safety. However, further research is needed to obtain more reliable results and more support from laboratory evidence.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Article Multidisciplinary Sciences

Interferon-γ enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis

Ryo Kanai et al.

Summary: Pre-treatment with IFN-gamma enhances the anti-fibrotic ability of MSCs, reducing inflammatory cell infiltration and improving interstitial fibrosis.

SCIENTIFIC REPORTS (2021)

Article Cell & Tissue Engineering

Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition

Jacques Galipeau et al.

Summary: The authors highlight the significant impact of in vivo persistence on the potency of MSCs, which may not be predicted by in vitro cellular potency assays and its translation to in vivo outcomes. Additionally, it is suggested that MSC viability and metabolic fitness play a dominant role in potency quality attributes, particularly in recipients identified by emerging predictive biomarkers of response.

CYTOTHERAPY (2021)

Article Chemistry, Multidisciplinary

Allogeneic mesenchymal stem cell sheet therapy: A new frontier in drug delivery systems

Kyungsook Kim et al.

Summary: The evolution of drug discovery in the early 20th century saw a shift from focusing on symptom control to pursuing radical cures, with cell therapy emerging as a promising new treatment targeting specific tissues and dynamic signaling environments. Cell delivery methods play a crucial role in realizing the therapeutic potential of cell therapy, especially in the context of mesenchymal stem cell (MSC) engraftment and bioactive function. Cell sheet technology is presented as a breakthrough in cell therapy, showcasing therapeutic success in tissue regeneration and discussing its anticipated clinical impacts.

JOURNAL OF CONTROLLED RELEASE (2021)

Review Cell Biology

Therapeutic Use of Mesenchymal Stromal Cells: The Need for Inclusive Characterization Guidelines to Accommodate All Tissue Sources and Species

Adrienne Wright et al.

Summary: The promise of MSCs as a therapeutic modality has not yet translated to consistent, successful clinical trial results in humans, despite preclinical data demonstrating their potential. MSC shareholders aim to improve the quality of life for patients with suboptimal or ineffective standard care. Although there are no FDA-approved MSC therapies in the US market, several MSC products have received regulatory approval in other countries.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Engineering, Biomedical

Strategies to address mesenchymal stem/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies

Celia M. Dunn et al.

Summary: Mesenchymal stromal cells (MSCs) have gained significant attention for their immunomodulatory potential, although their clinical success beyond safety is still controversial due to factors such as inconsistent sourcing, characterization, potency, and isolation protocols leading to functional heterogeneity. Homogeneous MSC populations may offer more predictable biological responses and clinically meaningful properties, addressing the challenge of immunomodulatory variabilities in cell-based therapies.

ACTA BIOMATERIALIA (2021)

Review Cell Biology

Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing

Premkumar Jayaraman et al.

Summary: Research shows that human mesenchymal stromal cells have potential applications in regenerative medicine and COVID-19 treatment, but challenges remain in manufacturing due to a lack of unified quality control standards. Proposed solutions for consistent GMP manufacturing of hMSCs include raw materials selection, closed and modular manufacturing systems, quality control, and safety testing.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Infectious Diseases

Microfluidic Tools for Enhanced Characterization of Therapeutic Stem Cells and Prediction of Their Potential Antimicrobial Secretome

Pasquale Marrazzo et al.

Summary: The potential of MSCs in treating bacterial diseases without the use of antibiotics is being explored, but issues with reproducibility and standardization of MSCs from different sources exist. Emerging microfluidic technologies may help improve the characterization of MSCs.

ANTIBIOTICS-BASEL (2021)

Article Dermatology

The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis

Emily H. Steen et al.

ADVANCES IN WOUND CARE (2020)

Review Pharmacology & Pharmacy

Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential

Na Song et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2020)

Article Multidisciplinary Sciences

Fabrication of hyaline-like cartilage constructs using mesenchymal stem cell sheets

Hallie Thorp et al.

SCIENTIFIC REPORTS (2020)

Review Biochemistry & Molecular Biology

Mesenchymal stem cells immunomodulation: The road to IFN-γ licensing and the path ahead

Amandda Evelin Silva-Carvalho et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2019)

Article Cell & Tissue Engineering

Rat Mesenchymal Stromal Cell Sheets Suppress Renal Fibrosis via Microvascular Protection

Aya Imafuku et al.

STEM CELLS TRANSLATIONAL MEDICINE (2019)

Review Materials Science, Biomaterials

Paracrine Effects of Mesenchymal Stromal Cells Cultured in Three-Dimensional Settings on Tissue Repair

Holly M. Wobma et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)

Review Materials Science, Biomaterials

Paracrine Effects of Mesenchymal Stromal Cells Cultured in Three-Dimensional Settings on Tissue Repair

Holly M. Wobma et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)

Review Cell & Tissue Engineering

Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities

Jacques Galipeau et al.

CELL STEM CELL (2018)

Review Urology & Nephrology

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

Yufang Shi et al.

NATURE REVIEWS NEPHROLOGY (2018)

Article Medicine, General & Internal

Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-gamma

Dae Seong Kim et al.

EBIOMEDICINE (2018)

Article Pharmacology & Pharmacy

Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study

Hyeon Gyu Yi et al.

KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2016)

Article Cell & Tissue Engineering

Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function

Kisha Nandini Sivanathan et al.

STEM CELLS (2015)

Article Biotechnology & Applied Microbiology

The Use of Scaffold-free Cell Sheet Technique to Refine Mesenchymal Stromal Cell-based Therapy for Heart Failure

Takuya Narita et al.

MOLECULAR THERAPY (2013)

Article Hematology

Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion

Xuebin Qu et al.

EXPERIMENTAL HEMATOLOGY (2012)

Article Biochemistry & Molecular Biology

Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy

Donald G. Phinney

JOURNAL OF CELLULAR BIOCHEMISTRY (2012)

Article Cell & Tissue Engineering

A Novel Stem Cell Tag-Less Sorting Method

Barbara Roda et al.

STEM CELL REVIEWS AND REPORTS (2009)

Article Immunology

IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

David Polchert et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2008)

Article Immunology

Stem cell transplantation: The lung barrier

S. Schrepfer et al.

TRANSPLANTATION PROCEEDINGS (2007)

Article Materials Science, Multidisciplinary

Cell sheet engineering

Masayuki Yamato et al.

MATERIALS TODAY (2004)